Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to the provisions of Regulation 30 of Listing Regulations, we hereby inform that the members of the Company at the 69th Annual General Meeting held today ('AGM'), have approved: (a) Appointment of Mr. Krishna Datla as a Whole-time Director of the Company, designated as Executive Vice-Chairman, for a period of 3 years w.e.f. May 9, 2021; (b) Appointment of Mr. Prashant Nagre, as a Director of the Company; and (c) Appointment of Mr. Prashant Nagre as Managing Director of the Company for a period of 3 years w.e.f. May 9, 2021. Requisite details of directors in terms of SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and affirmation pursuant to BSE Circular LIST/COMP/14/2018-19 dated June 20, 2018 are provided in Annexure 1 in respect of Mr. Krishna Datla and Mr. Prashant Nagre. The members also approved the appointment of Mr. Satish Varma (DIN - 00003255), who retired by rotation and, being eligible, offered himself for re-appointment.03-09-2021
